ANTIOXIDANT THERAPY WITH N-ACETYLCYSTEINE FOR MOTOR BEHAVIOR AND LEARNING IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

$1,268,303FY2020Defense Health AgencyDOD

Childrens Hospital Medical Center

Investigators